TNF and Alzheimer disease: It was reported that proinflammatory cytokines such as TNFα are elevated in the CSF and plasma of AD patients.55 Several biologic medications against TNFα have decreased Aβ deposition, behavioral impairments and inflammation in AD animal models,56-59 which suggest that TNFα is a deleterious agent in AD term and can serve as a reliable AD target.